Control of asthma by omalizumab: the role of CD4+ Foxp3+ regulatory T cells

Clin Exp Allergy. 2016 Dec;46(12):1614-1616. doi: 10.1111/cea.12839.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Asthmatic Agents / therapeutic use*
  • Asthma / drug therapy*
  • Asthma / immunology
  • CD4 Antigens
  • Child
  • Cross-Sectional Studies
  • Eosinophilia / drug therapy
  • Female
  • Flow Cytometry
  • Forkhead Transcription Factors / immunology*
  • Humans
  • Interleukin-2 Receptor alpha Subunit
  • Male
  • Omalizumab / therapeutic use*
  • Prospective Studies
  • T-Lymphocytes, Regulatory / cytology*
  • T-Lymphocytes, Regulatory / immunology

Substances

  • Anti-Asthmatic Agents
  • CD4 Antigens
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Interleukin-2 Receptor alpha Subunit
  • Omalizumab